Global Jet Lag Therapy Treatment Market, By Application (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, Others), Treatment Type (Sunlight, Bright Light Therapy, Melatonin Supplements, Sleeping Pills, Exercise, Others), Drugs (Nonbenzodiazepines, Benzodiazepines, Others), Route of Administration (Oral, Injectable) End-Users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Jet Lag Therapy Treatment Market
Jet lag therapy treatment market is expected to gain market growth at a potential rate of 4.25% in the forecast period of 2021 to 2028. Rise in the exposure to high altitudes and cabin pressures associated with air travel is the vital factor escalating the jet lag therapy treatment market growth.
Jet lag is also known as jet disorders or desynchronosis which is a temporary condition of circadian rhythm sleep disorder that occurs when anyone travel across multiple time zones. Jet lag is caused when the natural biological clock of the body does not correlate with the local time zone. Jet lag may lead to disturbance of bowel function, fatigue, trouble falling asleep and tiredness.
Rise in the change in the working shift timings associated with night shifts will uplift the market growth, also increase in the new launches of insomnia related products annually, increase in number of travelers who are traveling to different time zones and rapid increase in the number of air travelers along with minimal side-effects or complications of drugs are some of the crucial factors among others driving the jet lag therapy treatment market growth. Moreover, rise in the research and development activities in the market will further create new opportunities for the jet lag therapy treatment market in the forecast period of 2021-2028.
However, rise in the preference of non-pharmacological therapies over pharmacological therapies, increase in the introduction of alternative therapy to beat the jet lag disorders and limited efficacy rate of available intervention are the major factors among others acting as restraints, and will further challenge the jet lag therapy treatment market in the forecast period mentioned above.
Jet lag therapy treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the jet lag therapy treatment market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Jet Lag Therapy Treatment Market Scope and Market Size
Jet lag therapy treatment market is segmented on the basis of application, treatment type, drugs, route of administration and end-users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of application, jet lag therapy treatment market is segmented into business travelers, cabin crew, athletes, seasonal travelers and others.
- Based on treatment type, jet lag therapy treatment market is segmented into sunlight, bright light therapy, melatonin supplements, sleeping pills, exercise and others
- Based on drugs, jet lag therapy treatment market is segmented into nonbenzodiazepines, benzodiazepines and others.
- Based on route of administration, the jet lag therapy treatment market is segmented into oral and injectable.
- Jet lag therapy treatment market is also segmented on the basis of end-users into hospitals, homecare, specialty clinics and others.
Jet Lag Therapy Treatment Market Country Level Analysis
Jet lag therapy treatment market is analysed and market size information is provided by country, application, treatment type, drugs, route of administration and end-users as referenced above.
The countries covered in the jet lag therapy treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the jet lag therapy treatment market due to rise in the number of air travelers, convenience of direct purchase, high adoption and acceptance in developing markets, and innovations and developments in therapy in this region. Asia Pacific and Latin America are the expected region in terms of growth in jet lag therapy treatment market due to increase in the change in the working shift timings associated with night shifts in this region.
The country section of the jet lag therapy treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Jet lag therapy treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Jet Lag Therapy Treatment Market Share Analysis
Jet lag therapy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to jet lag therapy treatment market.
The major players covered in the jet lag therapy treatment market report are Clinigen Group plc, Vanda Pharmaceuticals, Pfizer Inc, Jamieson Laboratories Ltd., NOW Foods, Nature’s Bounty, ALEXZA, Jazz Pharmaceuticals, Inc, Eisai Co., Ltd and Purdue Pharma L.P among other domestic and global players. Osteoarthritic pain management treatment share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-